Intelicare Holdings Ltd (ICR) - Total Liabilities

Latest as of June 2026: AU$2.11 Million AUD ≈ $1.49 Million USD

Based on the latest financial reports, Intelicare Holdings Ltd (ICR) has total liabilities worth AU$2.11 Million AUD (≈ $1.49 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ICR financial resilience to evaluate the company's liquid asset resilience ratio.

Intelicare Holdings Ltd - Total Liabilities Trend (2018–2026)

This chart illustrates how Intelicare Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ICR current and non-current assets.

Intelicare Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of Intelicare Holdings Ltd ranked by their total liabilities.

Company Country Total Liabilities
RE Royalties Ltd
V:RE
Canada CA$45.99 Million
Active Biotech AB
ST:ACTI
Sweden Skr10.70 Million
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
USA $6.95 Million
CS Corporation
KQ:065770
Korea ₩2.63 Billion
Charn Issara Development Public Company Limited
BK:CI
Thailand ฿8.16 Billion
Netlinkz Ltd
AU:NET
Australia AU$28.13 Million
HANHUA FNCL HLDG CO.H YC1
F:5HF
Germany €5.03 Billion
Vaishali Pharma Limited
NSE:VAISHALI
India Rs-691.15 Million

Liability Composition Analysis (2018–2026)

This chart breaks down Intelicare Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Intelicare Holdings Ltd (ICR) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.57 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intelicare Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intelicare Holdings Ltd (2018–2026)

The table below shows the annual total liabilities of Intelicare Holdings Ltd from 2018 to 2026.

Year Total Liabilities Change
2026-06-30 AU$2.11 Million
≈ $1.49 Million
+13.56%
2025-06-30 AU$1.86 Million
≈ $1.31 Million
+10.09%
2024-06-30 AU$1.69 Million
≈ $1.19 Million
+9.91%
2023-06-30 AU$1.53 Million
≈ $1.08 Million
+14.54%
2022-06-30 AU$1.34 Million
≈ $947.10K
+58.85%
2021-06-30 AU$842.64K
≈ $596.22K
+11.81%
2020-06-30 AU$753.63K
≈ $533.24K
+175.47%
2019-06-30 AU$273.57K
≈ $193.57K
+2116.80%
2018-06-30 AU$12.34K
≈ $8.73K
--

About Intelicare Holdings Ltd

AU:ICR Australia Health Information Services
Market Cap
$11.64 Million
AU$16.45 Million AUD
Market Cap Rank
#26770 Global
#1246 in Australia
Share Price
AU$0.02
Change (1 day)
-4.17%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$0.48
About

Intelicare Holdings Limited engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia. The company offers a smart home and predictive analytics platform for caregivers to track activity levels, patterns of behavior, health metrics, sleep, and others to detect and help prevent incide… Read more